{"id":"https://openalex.org/W2804532233","doi":"https://doi.org/10.1371/journal.pone.0197670","title":"The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration\u2014A cost-effectiveness analysis from a societal perspective","display_name":"The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration\u2014A cost-effectiveness analysis from a societal perspective","alternate_titles":[],"publication_year":2018,"publication_date":"2018-05-17","ids":{"openalex":"https://openalex.org/W2804532233","doi":"https://doi.org/10.1371/journal.pone.0197670","mag":"2804532233","pmid":"https://pubmed.ncbi.nlm.nih.gov/29772018","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5957378"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0197670","doi":"https://doi.org/10.1371/journal.pone.0197670","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0197670","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0197670&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2804532233"],"child_works_count":8,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0197670&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051288303","display_name":"Freekje van Asten","orcid":"https://orcid.org/0000-0002-8141-4234","observed_orcids":["https://orcid.org/0000-0002-8141-4234"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/data-curation","display_name":"Data curation"},{"id":"https://openalex.org/contributor-roles/formal-analysis","display_name":"Formal analysis"},{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/project-administration","display_name":"Project administration"},{"id":"https://openalex.org/contributor-roles/supervision","display_name":"Supervision"},{"id":"https://openalex.org/contributor-roles/visualization","display_name":"Visualization"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Freekje van Asten","raw_affiliation_strings":["Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-8141-4234","affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004360380","display_name":"Charlotte T.J. Michels","orcid":"https://orcid.org/0000-0003-0111-1872","observed_orcids":["https://orcid.org/0000-0003-0111-1872"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/data-curation","display_name":"Data curation"},{"id":"https://openalex.org/contributor-roles/formal-analysis","display_name":"Formal analysis"},{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/project-administration","display_name":"Project administration"},{"id":"https://openalex.org/contributor-roles/visualization","display_name":"Visualization"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Charlotte T. J. Michels","raw_affiliation_strings":["Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086926273","display_name":"Carel B. Hoyng","orcid":"https://orcid.org/0000-0002-1358-5963","observed_orcids":["https://orcid.org/0000-0002-1358-5963"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/data-curation","display_name":"Data curation"},{"id":"https://openalex.org/contributor-roles/funding-acquisition","display_name":"Funding acquisition"},{"id":"https://openalex.org/contributor-roles/supervision","display_name":"Supervision"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Carel B. Hoyng","raw_affiliation_strings":["Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033676105","display_name":"Gert Jan van der Wilt","orcid":"https://orcid.org/0000-0002-5856-762X","observed_orcids":["https://orcid.org/0000-0002-5856-762X"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/data-curation","display_name":"Data curation"},{"id":"https://openalex.org/contributor-roles/funding-acquisition","display_name":"Funding acquisition"},{"id":"https://openalex.org/contributor-roles/supervision","display_name":"Supervision"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Gert Jan van der Wilt","raw_affiliation_strings":["Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026307484","display_name":"B. Jeroen Klevering","orcid":"https://orcid.org/0000-0002-3062-6544","observed_orcids":["https://orcid.org/0000-0002-3062-6544"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/data-curation","display_name":"Data curation"},{"id":"https://openalex.org/contributor-roles/funding-acquisition","display_name":"Funding acquisition"},{"id":"https://openalex.org/contributor-roles/supervision","display_name":"Supervision"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"B. Jeroen Klevering","raw_affiliation_strings":["Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053996737","display_name":"Maroeska Mariet Rovers","orcid":"https://orcid.org/0000-0002-3095-170X","observed_orcids":["https://orcid.org/0000-0002-3095-170X"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/data-curation","display_name":"Data curation"},{"id":"https://openalex.org/contributor-roles/formal-analysis","display_name":"Formal analysis"},{"id":"https://openalex.org/contributor-roles/funding-acquisition","display_name":"Funding acquisition"},{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/supervision","display_name":"Supervision"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Maroeska M. Rovers","raw_affiliation_strings":["Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089131541","display_name":"Janneke P.C. Grutters","orcid":"https://orcid.org/0000-0002-2579-1561","observed_orcids":["https://orcid.org/0000-0002-2579-1561"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/data-curation","display_name":"Data curation"},{"id":"https://openalex.org/contributor-roles/formal-analysis","display_name":"Formal analysis"},{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/methodology","display_name":"Methodology"},{"id":"https://openalex.org/contributor-roles/supervision","display_name":"Supervision"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Janneke P. C. Grutters","raw_affiliation_strings":["Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5051288303"],"corresponding_institution_ids":["https://openalex.org/I2802934949"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":14.8388,"has_fulltext":true,"cited_by_count":131,"citation_normalized_percentile":{"value":0.99611041,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"13","issue":"5","first_page":"e0197670","last_page":"e0197670"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.7968999743461609,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.7968999743461609,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.17870000004768372,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9440000057220459},{"id":"https://openalex.org/keywords/ranibizumab","display_name":"ranibizumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/aflibercept","display_name":"aflibercept","score":1.0},{"id":"https://openalex.org/keywords/neovascular-age-related-macular-degeneration","display_name":"neovascular age-related macular degeneration","score":0.9789999723434448},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9670000076293945},{"id":"https://openalex.org/keywords/societal-perspective","display_name":"societal perspective","score":0.6840000152587891},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.5680000185966492},{"id":"https://openalex.org/keywords/threshold-analysis","display_name":"threshold analysis","score":0.4790000021457672},{"id":"https://openalex.org/keywords/visual-acuity-outcomes","display_name":"visual acuity outcomes","score":0.5440000295639038},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.35899999737739563},{"id":"https://openalex.org/keywords/off-label-drug-use","display_name":"off-label drug use","score":0.6650000214576721}],"concepts":[{"id":"https://openalex.org/C2778749236","wikidata":"https://www.wikidata.org/wiki/Q4689286","display_name":"Aflibercept","level":4,"score":0.9686388373374939},{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.9167954921722412},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.9129127264022827},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.811956524848938},{"id":"https://openalex.org/C2776403814","wikidata":"https://www.wikidata.org/wiki/Q27429789","display_name":"Macular degeneration","level":2,"score":0.7308700680732727},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.4607679843902588},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.32220184803009033},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.1907132863998413},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.14603358507156372},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.07963991165161133}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000069579","descriptor_name":"Ranibizumab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069579","descriptor_name":"Ranibizumab","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000069579","descriptor_name":"Ranibizumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003661","descriptor_name":"Decision Support Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D011993","descriptor_name":"Recombinant Fusion Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017046","descriptor_name":"Cost Savings","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D040262","descriptor_name":"Receptors, Vascular Endothelial Growth Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D040262","descriptor_name":"Receptors, Vascular Endothelial Growth Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D056687","descriptor_name":"Off-Label Use","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D058449","descriptor_name":"Intravitreal Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":9,"locations":[{"id":"doi:10.1371/journal.pone.0197670","doi":"https://doi.org/10.1371/journal.pone.0197670","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0197670","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0197670&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5957378","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5957378/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmid:29772018","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29772018","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Comparative Study"},{"id":"pmh:oai:RePEc:plo:pone00:0197670","doi":null,"is_oa":false,"landing_page_url":"https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0197670","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:oai:doaj.org/article:c9f7841a3f55437fad75a1f5c938d417","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/c9f7841a3f55437fad75a1f5c938d417","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 13, Iss 5, p e0197670 (2018)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/6284807","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/The_cost-effectiveness_of_bevacizumab_ranibizumab_and_aflibercept_for_the_treatment_of_age-related_macular_degeneration_A_cost-effectiveness_analysis_from_a_societal_perspective/6284807","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"pmh:oai:repository.ubn.ru.nl:2066/201379","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/2066/201379","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article / Letter to editor"},{"id":"pmh:ru:oai:repository.ubn.ru.nl:2066/191974","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2066/191974","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS One, 13","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:ru:oai:repository.ubn.ru.nl:2066/196554","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2066/196554","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS One, 13","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0197670","doi":"https://doi.org/10.1371/journal.pone.0197670","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0197670","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0197670&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320336519","display_name":"Radboud Institute for Health Sciences","ror":"https://ror.org/00k5r1z23"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2804532233.pdf","grobid_xml":"https://content.openalex.org/works/W2804532233.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W124553853","https://openalex.org/W166560170","https://openalex.org/W1481978003","https://openalex.org/W1595046345","https://openalex.org/W1781561718","https://openalex.org/W1935342590","https://openalex.org/W1966486839","https://openalex.org/W1971734345","https://openalex.org/W1972305015","https://openalex.org/W1974946414","https://openalex.org/W1984817372","https://openalex.org/W1996067696","https://openalex.org/W1996171994","https://openalex.org/W2003324689","https://openalex.org/W2004117352","https://openalex.org/W2018324728","https://openalex.org/W2020732840","https://openalex.org/W2032968594","https://openalex.org/W2034060643","https://openalex.org/W2053567993","https://openalex.org/W2057628931","https://openalex.org/W2059547624","https://openalex.org/W2064453315","https://openalex.org/W2077891356","https://openalex.org/W2085442615","https://openalex.org/W2085712747","https://openalex.org/W2124415048","https://openalex.org/W2126693257","https://openalex.org/W2128911553","https://openalex.org/W2131553265","https://openalex.org/W2134161293","https://openalex.org/W2140018458","https://openalex.org/W2147741652","https://openalex.org/W2152152687","https://openalex.org/W2160226180","https://openalex.org/W2162339769","https://openalex.org/W2324562749","https://openalex.org/W2492738130","https://openalex.org/W4250031098"],"related_works":["https://openalex.org/W2064453315","https://openalex.org/W2010262292","https://openalex.org/W1976000255","https://openalex.org/W2142475605","https://openalex.org/W4110361","https://openalex.org/W2080864067","https://openalex.org/W3164916218","https://openalex.org/W4402843050","https://openalex.org/W3207043302","https://openalex.org/W2339066515"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,97,275],"discussion":[2],"on":[3,249],"the":[4,43,51,62,100,125,130,134,186,204,222,232,260,269],"use":[5,50],"of":[6,65,79,271],"bevacizumab":[7,18,87,107,152,184,297],"is":[8,26,153,210,238,259,267],"still":[9],"ongoing":[10],"and":[11,30,58,86,95,133,169,279],"often":[12],"doctors":[13],"are":[14],"deterred":[15],"from":[16,71],"using":[17],"due":[19],"to":[20,106,128,141,207,282,295],"legal":[21],"or":[22],"political":[23],"issues.":[24],"Bevacizumab":[25,158,258],"an":[27],"effective,":[28],"safe":[29],"inexpensive":[31],"treatment":[32,70,80,159,237,251,263],"option":[33],"for":[34,42,110,137,177,192,235,264],"neovascular":[35],"age-related":[36],"macular":[37],"degeneration":[38],"(AMD),":[39],"albeit":[40],"unregistered":[41],"disease.":[44],"Therefore,":[45],"in":[46],"some":[47],"countries":[48],"ophthalmologists":[49],"equally":[52],"effective":[53],"but":[54,200],"expensive":[55],"drugs":[56,179,277],"ranibizumab":[57,82,278],"aflibercept.":[59],"We":[60,76],"describe":[61],"economic":[63],"consequences":[64],"this":[66],"dilemma":[67],"surrounding":[68],"AMD":[69,250],"a":[72,138],"societal":[73],"perspective.":[74],"METHODS:":[75],"modelled":[77],"cost-effectiveness":[78,103],"with":[81,99],"(as-needed),":[83],"aflibercept":[84,168,217,254,280],"(bimonthly)":[85],"(as-needed).":[88],"Effectiveness":[89],"was":[90,108,185,190],"estimated":[91,146],"by":[92,182],"systematic":[93],"review":[94],"meta-analysis.":[96],"drug":[98,139],"most":[101,187,261],"favourable":[102],"profile":[104],"compared":[105],"used":[109],"threshold":[111,193],"analyses.":[112,194],"First,":[113],"we":[114,118,123,145,201],"determined":[115,202],"how":[116,147],"much":[117,148],"overspend":[119],"per":[120,162,198,240],"injection.":[121],"Second,":[122],"calculated":[124],"required":[126],"effectiveness":[127,176],"justify":[129],"current":[131,215],"price":[132,136,206,234],"reasonable":[135],"leading":[140],"optimal":[142,227],"vision.":[143],"Finally,":[144],"Europe":[149,244],"overspends":[150,245],"if":[151],"not":[154,268],"first":[155,302],"choice.":[156,303],"RESULTS:":[157],"costs":[160,196],"\u20ac27,087":[161],"year,":[163],"about":[164,220],"\u20ac4,000":[165],"less":[166,171],"than":[167,172],"\u20ac6,000":[170],"ranibizumab.":[173],"With":[174],"similar":[175],"all":[178],"as":[180,301],"shown":[181],"meta-analysis,":[183],"cost-effective.":[188],"Aflibercept":[189,195],"chosen":[191],"\u20ac943":[197],"injection,":[199],"that":[203],"maximum":[205,233],"be":[208,230],"cost-effective":[209,262],"\u20ac533.":[211],"Alternatively,":[212],"at":[213],"its":[214],"price,":[216],"should":[218,291],"yield":[219],"twice":[221],"visual":[223],"gain.":[224],"Even":[225],"when":[226,252],"vision":[228],"can":[229],"achieved,":[231],"any":[236],"\u20ac37,453":[239],"year.":[241],"Most":[242],"importantly,":[243],"\u20ac335":[246],"million":[247],"yearly":[248],"choosing":[253],"over":[255],"bevacizumab.":[256],"CONCLUSION:":[257],"AMD,":[265],"yet":[266],"standard":[270],"care":[272],"across":[273],"Europe.":[274],"registered":[276],"lead":[281],"large":[283],"overspending":[284],"without":[285],"additional":[286],"health":[287],"benefits.":[288],"Health":[289],"authorities":[290],"consider":[292],"taking":[293],"steps":[294],"implement":[296],"into":[298],"clinical":[299],"practice":[300]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2804532233","counts_by_year":[{"year":2026,"cited_by_count":16},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":21},{"year":2020,"cited_by_count":28},{"year":2019,"cited_by_count":14},{"year":2018,"cited_by_count":2},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-06-01T00:00:00"}
